| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4024788 | Journal Français d'Ophtalmologie | 2009 | 6 Pages |
Abstract
Combined orally and topically administered voriconazole is a promising therapy when the minimum inhibitory concentration is approximately 2 μg/ml. Liposomal amphotericin B seems to be the most effective drug for the different infection stages. Posaconazole is a useful alternative but further investigations must be pursued.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
G. Touvron, D. Denis, M. Doat, A. Girard, M.-L. Brandely, F. Chast, G. Renard,